help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-2015
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammer, S.
Right arrow Articles by Romijn, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammer, S.
Right arrow Articles by Romijn, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Diets
Related Collections
Right arrow Lipid
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 2 497-503
Copyright © 2008 by The Endocrine Society

Progressive Caloric Restriction Induces Dose-Dependent Changes in Myocardial Triglyceride Content and Diastolic Function in Healthy Men

Sebastiaan Hammer1, Rutger W. van der Meer1, Hildo J. Lamb, Michael Schär, Albert de Roos, Jan W. A. Smit and Johannes A. Romijn

Departments of Endocrinology and Metabolism (S.H., R.W.v.d.M., J.W.A.S., J.A.R.) and Radiology (S.H., R.W.v.d.M., H.J.L., A.d.R.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands; Russell H. Morgan Department of Radiology and Radiological Science (M.S.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21287; and Philips Medical Systems (M.S.), Cleveland, Ohio 44106

Address all correspondence and requests for reprints to: S. Hammer, Department of Endocrinology and Metabolism (C4-R), Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: S.Hammer{at}LUMC.nl.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Context: In animal experiments, high plasma concentrations of free fatty acids (FFAs) are associated with increased triglyceride (TG) stores in liver and heart, and impaired cardiac function. In humans caloric restriction increases plasma FFA levels.

Objective: Our objective was to assess the effects of progressive caloric restriction on myocardial and hepatic TG content and myocardial function.

Design: This was a prospective intervention study.

Participants: This study included 10 lean healthy men.

Interventions: Three-day partial (471 kcal/d) and complete starvation was performed.

Outcome Measures: Plasma levels of FFA, myocardial and hepatic TG content, and myocardial function were calculated.

Results: Plasma FFA increased from 0.6 ± 0.4 mmol/liter to 1.2 ± 0.4 and to 1.9 ± 0.7 mmol/liter, after partial and complete starvation, respectively (P < 0.001). Myocardial TG content increased from 0.35 ± 0.14% to 0.59 ± 0.27%, and 1.26 ± 0.49%, respectively (P < 0.01). The ratio between the early diastole and atrial contraction decreased from 2.2 ± 0.4 to 2.1 ± 0.4 (P = 0.7) and 1.8 ± 0.4, respectively (P < 0.01), and diastolic early deceleration from 3.4 ± 0.7 ml/sec2 x 10–3 to 2.9 ± 0.5 and 2.8 ± 0.9 ml/sec2 x 10–3, respectively (P < 0.05). Hepatic TG content decreased after partial starvation (from 2.23 ± 2.24% to 1.43 ± 1.33%; P < 0.05) but did not change upon complete starvation.

Conclusions: Progressive caloric restriction induces a dose-dependent increase in myocardial TG content and a dose-dependent decrease in diastolic function in lean healthy men. Hepatic TG content showed a differential response to progressive caloric restriction, indicating that redistribution of endogenous TG stores is tissue specific.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Almost all endogenous triglycerides (TGs) are stored in adipose tissue to accommodate discrepancies between whole body fat uptake and fat oxidation. However, a very small proportion is stored in nonadipose tissues like the heart (1), the liver (2), and skeletal muscle (3), especially in obesity and type 2 diabetes mellitus. There are indications that this storage of TG in nonadipose tissues is not merely an inert phenomenon but is associated with more or less subtle physiological changes in organ-specific functioning (4, 5, 6, 7, 8). In animal models there is an inverse relation between myocardial TG content and myocardial function. For example, myocardial lipid accumulation is associated with a decrease in left ventricular systolic function in obese Zucker rats, and treatment with thiazolidinediones reduces myocardial TG content and improves left ventricular function (8). The underlying mechanisms of the decrease in left ventricular function are complex and are related to effects of fatty acid (FA) derivatives, like fatty acyl-coenzyme A, ceramides, and diacylglycerol (4, 5, 7).

High plasma concentrations of free fatty acids (FFAs) may result in excessive FA uptake in nonadipose tissues, such as the liver and heart, which may affect normal organ function (7, 8). However, in humans the relation between myocardial TG accumulation and myocardial function was difficult to study by noninvasive methods because measurement of myocardial TG content is challenging due to artifacts induced by cardiac and respiratory motion. Recently, proton magnetic resonance spectroscopy (MRS) of the heart was developed that enables the measurement of myocardial TG content in humans in vivo (1, 10, 11, 12, 13). Using this method, Reingold et al. (14) documented that fasting for 48 h increases plasma FFA levels and myocardial TG content in healthy subjects, whereas myocardial TG content did not change after a single high fat meal. In another, cross-sectional study, Kankaanpää et al. (12) showed that increased levels of plasma FFA in obese subjects correlate positively with myocardial TG content and inversely with cardiac function. However, both studies did not address the relation between myocardial function in relation to myocardial TG content within the same subjects. In a recent study, we documented that the use of a very low calorie diet increases plasma FFA and myocardial TG content, associated with a decrease in myocardial diastolic function (15). Therefore, it appears that myocardial TG content is not fixed but varies within the same subject according to physiological conditions. It is yet unknown whether our recent findings of myocardial flexibility can be extrapolated when caloric restriction is progressively increased. Therefore, the aim of the present study was to extend the conditions of partial caloric restriction to complete caloric restriction, i.e. complete starvation. For this purpose we compared baseline observations with those obtained after 3-d partial starvation (471 kcal/d) and after 3-d complete starvation with respect to plasma levels of FFA, myocardial TG content, myocardial function, and hepatic TG content.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

There were 10 nonsmoking, healthy men included in this study [age; mean ± SD: 23.7 ± 4.7 yr, range 20.8–36.0 yr; body mass index (BMI): 23.6 ± 0.9 kg/m2]. Women were excluded because the hormonal status or contraceptive use may affect lipid metabolism (16). The study population was partly based on a previous cohort (15). In each subject, medical history was obtained, and physical examination was performed. An electrocardiogram (ECG) was made during the first visit. Subjects with any aberrations on the ECG were excluded. In addition, a 2-h 75 g oral glucose tolerance test was performed in the fasted state, to exclude subjects suffering from diabetes mellitus (17). Other exclusion criteria were: obesity (BMI > 30 kg/m2); liver disease (increased plasma levels of alanine aminotransferase, aspartate aminotransferase, and/or {gamma}-glutamyl transferase > 2 SD above the reference value of our institution); renal disease (defined by plasma creatinine levels > 2 SD above the reference value of our institution); use of any medication; and a history of (congenital) heart disease. Specifically, subjects with prior or present coronary artery disease (based on medical history) or hypertension (defined as sitting systolic blood pressure > 130 mm Hg and/or diastolic blood pressure > 85 mm Hg) were excluded. Written informed consent was obtained from all participants before the study. The local ethics committee approved the study.

Study design

The study consisted of three conditions. Baseline measurements were made, while subjects followed a normal diet but abstained from alcohol for 3 d (mean intake 2065 kcal/d). Subjects were admitted 4 h after the last meal for measurement of plasma concentrations of glucose, insulin, and lipids, and for evaluation by magnetic resonance imaging (MRI) and MRS. The second measurement was performed after a 3-d period of partial caloric restriction (471 kcal/d; Modifast Intensive, Nutrition & Santé Benelux, Breda, The Netherlands). The third measurement was performed after a 3-d period of complete starvation (0 kcal/d, only water was allowed), after which subjects were again admitted for blood sampling and MRI/MRS evaluation. Plasma concentrations of FFA and insulin were used to assess study compliance (18). Between all study occasions, a washout period with a minimum of 14 d was acquired (19), and the sequence of the second and third occasions was determined by balanced assignment.

1H-MRS of the liver and the heart

All MRI/MRS measurements were performed on a 1.5-Tesla Gyroscan ACS-NT MRI scanner (Philips Medical Systems, Best, The Netherlands) in the supine position. Localized single voxel (2 x 2 x 2 cm for the liver and 2 x 4 x 1 cm for the heart) spectra were recorded using a body coil for radiofrequency transmission and a surface coil (Ø 17 cm) for signal receiving. For the heart, the spectral volume was placed in the interventricular septum on four-chamber and short axis images at end systole, avoiding contamination with epicardial fat (Fig. 1Go). Data collection was double triggered using ECG triggering and navigator echoes for compensation of respiratory motion as described earlier (13). For the liver, voxel sites were matched at both study occasions, carefully avoiding blood vessels and bile ducts. To detect weak lipid signals, water-suppressed spectra with 128 averages for the heart and 64 for the liver were collected. Spectral parameters were: a repetition time (TR) of 3000 msec, echo time (TE) of 26 msec, and 1024 data points over 1000 kHz spectral width. In the same voxel, using the same parameters except for a TR of 10,000 msec, unsuppressed spectra with four averages were collected. Spectra were analyzed in the time domain, using Java-based MR user interface software and prior knowledge files [version 2.2 (20)], as described earlier (13). Peak estimates of lipid resonances of myocardial TG at 1.3 parts per million (ppm) and 0.9 ppm were summed and calculated as a percentage of the unsuppressed water signal (TG content, TG/water x100).


Figure 1
View larger version (99K):
[in this window]
[in a new window]

 
FIG. 1. Myocardial spectroscopic volume. Localization of the myocardial spectral voxel in the four-chamber (A) and short axis views (B).

 
MRI of the heart

Imaging of the heart was performed using a body coil for radiofrequency transmission and a five-element synergy coil for signal receiving. To assess systolic function, the heart was imaged from apex to base with 12–14 imaging levels (dependent on the heart size) in short axis view using an ECG triggered, sensitivity encoding balanced steady-state free procession sequence. Imaging parameters were a field-of-view of 400 mm, a matrix size of 256 x 256, a slice thickness of 10 mm, a slice gap of 0 mm, a flip angle of 35°, a TE of 1.67 msec, and a TR of 3.34 msec. Temporal resolution was 25–39 msec. End diastolic and end systolic images were identified on all slices, and endocardial contours were drawn using MASS post processing software (Medis, Leiden, The Netherlands) as described previously (21). Left ventricular ejection fraction (LVEF) was calculated for the assessment of systolic function. Furthermore, an ECG-gated gradient-echo sequence with velocity encoding was performed to measure blood flow across the mitral valve for the determination of left ventricular diastolic function (22, 23). Imaging parameters included the following: a TE of 5 msec, a TR of 14 msec, a flip angle of 20°, a slice thickness of 8 mm, a field-of-view of 350 mm, a matrix size of 256 x 256, a velocity encoding of 100 cm/sec, and a scan percentage of 80%. Flow velocities in early diastole (E) and at atrial contraction (A) were measured, and their peak flow ratio was calculated (E/A ratio) using the FLOW analytical software package (Medis) by defining a region of interest on the modulus images in all cardiac phases. Furthermore, the mean deceleration of the E wave and an estimation of left ventricular filling pressures (E/Ea) (24) were measured. All spectroscopic and functional analyses were performed by an experienced observer, blinded to the interventions. During MRI, blood pressure and heart rate were measured twice with an automatic device (Dinamap DPC100X; Freiburg, Germany) and averaged for analysis.

Assays

Glucose, total cholesterol (TC), and TG were measured on a fully automated P800 analyzer (Roche, Almere, The Netherlands) and insulin on a Immulite 2500 random access analyzer with a chemoluminescence immunoassay (Diagnostic Products Corp., Los Angeles, CA). Coefficients of variation were less than 2% for glucose, TC, and TG, and less than 5% for insulin. Plasma FFAs were measured using a commercial kit (FFA-C; Wako Chemicals, Neuss, Germany).

Statistical analysis

All statistical analyses were performed using SPSS, version 12.01 (SPSS, Inc., Chicago, IL). Statistical comparisons among the three physiological conditions were made by repeated measures ANOVA. Pearson r values were used for correlation analysis. Data are shown as mean ± SD. P < 0.05 (two tailed) was considered significant. Based on a previous report, we expected a decrease in diastolic early deceleration. Therefore, P < 0.05 (one tailed) was considered significant for this parameter (15).


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Metabolic effects of progressive caloric restriction (Table 1Go)

Subject characteristics at baseline, after partial starvation, and after complete starvation are shown in Table 1Go. Postabsorptive plasma glucose levels decreased from 5.0 ± 0.3 mmol/liter at baseline to 4.3 ± 0.4 mmol/liter after partial (P = 0.001) and to 3.9 ± 0.5 mmol/liter after complete starvation (P < 0.001). This was associated with a dose-dependent decrease in plasma insulin levels. Simultaneously, plasma concentrations of FFA increased dose dependently from 0.6 ± 0.4 mmol/liter to 1.2 ± 0.4 mmol/liter after partial (P < 0.001) and to 1.9 ± 0.7 mmol/liter after complete starvation (P < 0.001). Plasma TG levels decreased after partial starvation (from 1.3 ± 0.4 mmol/liter to 0.9 ± 0.3 mmol/liter (P = 0.009) but did not change upon complete starvation (P = 0.677). TC increased from 5.0 ± 1.3 mmol/liter at baseline to 5.1 ± 1.4 mmol/liter after partial (P = 0.810) and to 5.9 ± 1.8 mmol/liter after complete starvation (P = 0.005).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Metabolic response to progressive caloric restriction

 
Effects of progressive caloric restriction on myocardial and hepatic TG content

Myocardial TG content increased dose dependently from 0.35 ± 0.14% at baseline to 0.59 ± 0.27% after partial (P = 0.006) and to 1.26 ± 0.49% after complete starvation (P < 0.001; Fig. 2Go). Hepatic TG content correlated with BMI at baseline (r = 0.67; P = 0.033). Hepatic TG content significantly decreased after partial starvation (from 2.24 ± 2.24% to 1.43 ± 1.33%; P = 0.031), whereas it did not change after complete starvation (2.54 ± 2.53%; P = 0.378; Fig. 3Go).


Figure 2
View larger version (9K):
[in this window]
[in a new window]

 
FIG. 2. Myocardial TG content at baseline, and after partial and complete starvation. Typical proton spectra of myocardial TG content of one subject at baseline, and after partial and complete starvation scaled relative to baseline (A) and individual changes in myocardial TG content upon complete starvation (n = 10) (B). Vertical lines represent mean ± SD. *, P < 0.01 vs. baseline.

 

Figure 3
View larger version (12K):
[in this window]
[in a new window]

 
FIG. 3. Hepatic TG content at baseline, and after partial and complete starvation. Individual changes in hepatic TG content upon complete starvation (n = 10). Vertical lines represent mean ± SD. *, P < 0.05 vs. baseline.

 
Effects of progressive caloric restriction on myocardial function (Table 2Go)

Systolic and diastolic blood pressure, heart rate, and myocardial LVEF did not change significantly during/after partial and complete starvation, compared with baseline. Furthermore, estimated left ventricular filling pressures were unchanged after partial (8.8 ± 3.8; P = 0.742) and complete starvation (8.2 ± 2.5; P = 0.299) compared with baseline (9.3 ± 2.6). Diastolic E/A ratio decreased dose dependently from 2.2 ± 0.4 at baseline to 2.1 ± 0.4 after partial starvation (P = 0.687) and to 1.8 ± 0.4 after complete starvation (P = 0.005). E deceleration decreased dose dependently from 3.4 ± 0.7 ml/sec2 x 10–3 at baseline to 2.9 ± 0.5 x 10–3 ml/sec2 after partial (P = 0.036) and to 2.8 ± 0.9 after complete starvation (P = 0.032).


View this table:
[in this window]
[in a new window]

 
TABLE 2. Effects of progressive caloric restriction on myocardial function

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
This study demonstrates that progressive caloric restriction increases myocardial TG content in lean healthy men. This increase is paralleled by decreased diastolic myocardial function. In addition, the results document a dose-dependent effect between the degree of caloric restriction and the myocardial effects. These observations point to physiological variations in myocardial TG content and diastolic function. The effect of caloric restriction on redistribution of endogenous TG stores is tissue specific because we demonstrated differential effects of partial and complete starvation on liver TG content.

Different degrees of starvation were associated with a considerable increase in plasma FFA levels, in accordance with previous observations (25, 26). These increased FFA levels reflect increased lipolysis of TG content in adipose tissue. Apparently, during starvation myocardial FA uptake exceeds the requirements of myocardial FA oxidation, resulting in increased TG stores. Moreover, progressive caloric restriction has dose-dependent effects on myocardial TG accumulation and myocardial function. However, a causal relationship between myocardial TG content and myocardial function cannot be derived from the present data.

Our data are supported by animal experiments. In those studies excessive exposure of the myocardium to plasma FA is accompanied by increased storage of myocardial TGs, resulting in the production of FA intermediates, and ultimately deteriorations in myocardial function (8, 27, 28). Accordingly, it has been suggested that in obese subjects, subclinical diastolic dysfunction is due to changes in myocardial metabolism (29, 30, 31, 32). Kankaanpää et al. (12) reported that alterations in left ventricular function in moderate obese subjects are associated with increased myocardial TG content, compared with lean subjects. Moreover, Szczepaniak et al. (1) showed increased myocardial TG content in overweight and obese subjects, which was accompanied by increased left ventricular mass. In accordance with our study, Reingold et al. (14) documented that short-term fasting leads to myocardial TG accumulation, although they did not document effects on myocardial function. The current results, documenting dose-dependent effects of caloric restriction on levels of plasma FFA, myocardial TG content, and diastolic function, extend these findings and support the general concept that increased myocardial TG content is associated with decreased myocardial function (33). Alternatively, starvation profoundly alters endogenous metabolic regulation and other, yet undefined, metabolic effects than merely increased levels of plasma FFA and myocardial TG content, which may be involved in explaining the reduction in myocardial diastolic function. For example, caloric restriction might change calcium homeostasis in the myocardium (34), which affects myocardial diastolic function (35).

Transmitral flow velocities are load dependent and can be affected by changes in intravascular volume. However, estimated left ventricular filling pressures were unchanged upon progressive caloric restriction. Therefore, we believe that the observed change in transmitral flow patterns results from a change in the relaxation of the left ventricle. Caloric restriction enhances adipose tissue lipolysis, reflected in increased levels of plasma FFA, due to reduced insulin levels. Similar to our results in the heart, others found corresponding results of increased TG content of skeletal muscle after fasting (19, 25, 26). Starvation affects more parameters of lipid metabolism because plasma FFAs stimulate the hepatic production of very low density lipoprotein (VLDL), which is an important supplier for TG to the heart (36, 37). Plasma FFA levels also increase during starvation and most likely will contribute to increased myocardial TG levels. However, the relative contribution of albumin-bound FAs vs. FAs derived from VLDL-TG to myocardial TG stores during caloric restriction cannot be derived from the present data.

We found a correlation between hepatic fat content and BMI, in accordance with previous observations (2, 38). However, despite the increase in the flux of plasma FFA to the liver, considering the increased plasma FFA levels, hepatic TG content was decreased after partial starvation but was unchanged after complete starvation. In line with our results, Westerbacka et al. (9) previously documented that a low fat diet in moderately obese women decreases hepatic TG content. Because hepatic TG content is tightly regulated by the balance of hepatic FA uptake, hepatic FA oxidation, and output of VLDL-TG particles, it is possible that this hepatic balance between FA uptake and TG output is differentially affected by partial and complete starvation. Nonetheless, our data indicate that progressive caloric restriction differentially affects tissue-specific stores of TG in heart and liver, and prove that myocardial TG content and myocardial function vary depending on nutritional conditions, at least with respect to progressive degrees of starvation. Additional studies are required to elucidate to which extent these results can be extrapolated to clinically relevant conditions like type 2 diabetes mellitus and obesity.

In conclusion, progressive caloric restriction induces a dose-dependent increase in myocardial TG content and a dose-dependent decrease in diastolic function in lean healthy men. Hepatic TG content showed a differential response to progressive caloric restriction, indicating that redistribution of endogenous TG stores is tissue specific, at least in lean healthy men.


    Footnotes
 
Disclosure Summary: S.H., R.W.v.d.M., H.J.L., A.d.R., J.W.A.S., and J.A.R. have nothing to declare. M.S. is employed by Philips Medical Systems. This author provided technical and intellectual input. The authors who were not employed by Philips Medical Systems had full control of the inclusion of the data and information that might have presented a conflict of interest for this author.

First Published Online November 20, 2007

1 S.H. and R.W.v.d.M. contributed equally. Back

Abbreviations: A, Atrial contraction; BMI, body mass index; E, early diastole; ECG, electrocardiogram; FA, fatty acid; FFA, free FA; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; ppm, parts per million; TC, total cholesterol; TE, echo time; TG, triglyceride; TR, repetition time; VLDL, very low density lipoprotein.

Received September 7, 2007.

Accepted November 13, 2007.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D’Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG 2003 Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49:417–423[CrossRef][Medline]
  2. Ishii M, Yoshioka Y, Ishida W, Kaneko Y, Fujiwara F, Taneichi H, Miura M, Toshihiro M, Takebe N, Iwai M, Suzuki K, Satoh J 2005 Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects. Tohoku J Exp Med 206:23–30[CrossRef][Medline]
  3. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI, Caprio S 2002 Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51:1022–1027[Abstract/Free Full Text]
  4. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH 1994 β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 91:10878–10882[Abstract/Free Full Text]
  5. Shimabukuro M, Zhou YT, Levi M, Unger RH 1998 Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 95:2498–2502[Abstract/Free Full Text]
  6. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490[Abstract/Free Full Text]
  7. Unger RH, Orci L 2001 Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15:312–321[Abstract/Free Full Text]
  8. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH 2000 Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97:1784–1789[Abstract/Free Full Text]
  9. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, Yki-Jarvinen H 2005 Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804–2809[Abstract/Free Full Text]
  10. den Hollander JA, Evanochko WT, Pohost GM 1994 Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging. Magn Reson Med 32:175–180[Medline]
  11. Felblinger J, Jung B, Slotboom J, Boesch C, Kreis R 1999 Methods and reproducibility of cardiac/respiratory double-triggered (1)H-MR spectroscopy of the human heart. Magn Reson Med 42:903–910[CrossRef][Medline]
  12. Kankaanpää M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P 2006 Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91:4689–4695[Abstract/Free Full Text]
  13. van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ 2007 Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 245:251–257[Abstract/Free Full Text]
  14. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS 2005 Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289:E935–E939
  15. van der Meer RW, Hammer S, Smit JW, Frolich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb H 2007 Short term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 56:2849–2853[CrossRef][Medline]
  16. ESHRE Capri Workshop Group 2006 Hormones and cardiovascular health in women. Hum Reprod Update 12:483–497[Abstract/Free Full Text]
  17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5–S20
  18. Klein S, Sakurai Y, Romijn JA, Carroll RM 1993 Progressive alterations in lipid and glucose metabolism during short-term fasting in young adult men. Am J Physiol 265(5 Pt 1):E801–E806
  19. Johnson NA, Stannard SR, Rowlands DS, Chapman PG, Thompson CH, O’Connor H, Sachinwalla T, Thompson MW 2006 Effect of short-term starvation versus high-fat diet on intramyocellular triglyceride accumulation and insulin resistance in physically fit men. Exp Physiol 91:693–703[Abstract/Free Full Text]
  20. Vanhamme L, van den BA, Van Huffel S 1997 Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35–43[CrossRef][Medline]
  21. Pattynama PM, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A 1993 Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology 187:261–268[Abstract/Free Full Text]
  22. Hartiala JJ, Mostbeck GH, Foster E, Fujita N, Dulce MC, Chazouilleres AF, Higgins CB 1993 Velocity-encoded cine MRI in the evaluation of left ventricular diastolic function: measurement of mitral valve and pulmonary vein flow velocities and flow volume across the mitral valve. Am Heart J 125:1054–1066[CrossRef][Medline]
  23. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A 1999 Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99:2261–2267[Abstract/Free Full Text]
  24. Paelinck BP, de Roos A, Bax JJ, Bosmans JM, Der Geest RJ, Dhondt D, Parizel PM, Vrints CJ, Lamb HJ 2005 Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45:1109–1116[Abstract/Free Full Text]
  25. Stannard SR, Thompson MW, Fairbairn K, Huard B, Sachinwalla T, Thompson CH 2002 Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men. Am J Physiol Endocrinol Metab 283:E1185–E1191
  26. Wietek BM, Machann J, Mader I, Thamer C, Haring HU, Claussen CD, Stumvoll M, Schick F 2004 Muscle type dependent increase in intramyocellular lipids during prolonged fasting of human subjects: a proton MRS study. Horm Metab Res 36:639–644[CrossRef][Medline]
  27. Christoffersen C, Bollano E, Lindegaard ML, Bartels ED, Goetze JP, Andersen CB, Nielsen LB 2003 Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144:3483–3490[CrossRef][Medline]
  28. Ouwens DM, Boer C, Fodor M, de Galan P, Heine RJ, Maassen JA, Diamant M 2005 Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia 48:1229–1237[CrossRef][Medline]
  29. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H 2004 Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18:1692–1700[Abstract/Free Full Text]
  30. de Las FL, Waggoner AD, Brown AL, Davila-Roman VG 2005 Plasma triglyceride level is an independent predictor of altered left ventricular relaxation. J Am Soc Echocardiogr 18:1285–1291[CrossRef][Medline]
  31. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK 2003 Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42:328–335[Abstract/Free Full Text]
  32. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ 2004 Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109:2191–2196[Abstract/Free Full Text]
  33. McGavock JM, Victor RG, Unger RH, Szczepaniak LS 2006 Adiposity of the heart, revisited. Ann Intern Med 144:517–524[Abstract/Free Full Text]
  34. Han X, Cheng H, Mancuso DJ, Gross RW 2004 Caloric restriction results in phospholipid depletion, membrane remodeling, and triacylglycerol accumulation in murine myocardium. Biochemistry 43:15584–15594[CrossRef][Medline]
  35. Zile MR, Brutsaert DL 2002 New concepts in diastolic dysfunction and diastolic heart failure. Part II: causal mechanisms and treatment. Circulation 105:1503–1508[Free Full Text]
  36. Goudriaan JR, Tacken PJ, Dahlmans VE, Gijbels MJ, van Dijk KW, Havekes LM, Jong MC 2001 Protection from obesity in mice lacking the VLDL receptor. Arterioscler Thromb Vasc Biol 21:1488–1493[Abstract/Free Full Text]
  37. Sakai J, Hoshino A, Takahashi S, Miura Y, Ishii H, Suzuki H, Kawarabayasi Y, Yamamoto T 1994 Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem 269:2173–2182[Abstract/Free Full Text]
  38. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, Fredriksson J, Yki-Jarvinen H 2004 Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47:1360–1369[Medline]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Iozzo, R. Lautamaki, R. Borra, H.-R. Lehto, M. Bucci, A. Viljanen, J. Parkka, V. Lepomaki, R. Maggio, R. Parkkola, et al.
Contribution of Glucose Tolerance and Gender to Cardiac Adiposity
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4472 - 4482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Suzuki, M. Ueno, M. Uno, Y. Hirose, Y. Zenimaru, S. Takahashi, J.-i. Osuga, S. Ishibashi, M. Takahashi, M. Hirose, et al.
Effects of hormone-sensitive lipase disruption on cardiac energy metabolism in response to fasting and refeeding
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1115 - E1124.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Hammer, M. Snel, H. J. Lamb, I. M. Jazet, R. W. van der Meer, H. Pijl, E. A. Meinders, J. A. Romijn, A. de Roos, and J. W.A. Smit
Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Myocardial Triglyceride Content and Improves Myocardial Function
J. Am. Coll. Cardiol., September 16, 2008; 52(12): 1006 - 1012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Hammer, R. W. van der Meer, H. J. Lamb, H. H. de Boer, J. J. Bax, A. de Roos, J. A. Romijn, and J. W. A. Smit
Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E714 - E718.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Hammer, J. T. Jonker, H. J. Lamb, R. W. van der Meer, W. Zondag, J. M. Sepers, A. de Roos, J. W.A. Smit, and J. A. Romijn
Short-Term Hyperglycemic Dysregulation in Patients With Type 1 Diabetes Does Not Change Myocardial Triglyceride Content or Myocardial Function
Diabetes Care, August 1, 2008; 31(8): 1613 - 1614.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammer, S.
Right arrow Articles by Romijn, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammer, S.
Right arrow Articles by Romijn, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Diets
Related Collections
Right arrow Lipid
Right arrow Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals